Search

Trans Pathways researcher recognised as one of Australia’s Tomorrow Makers

Youth mental health researcher Penelope Strauss has been named an AMP Tomorrow Maker – the first researcher from The Kids Research Institute Australia to win one of the annual AMP Foundation grants.

New research calls for re-introduction of sugar intake monitoring

A new study by the Telethon Institute for Child Health Research has called for better collection of data on food sugar levels as obesity levels continue to rise

Vitamin D levels linked to depression in young men

Research from Perth's The Kids for Child Health Research shows that symptoms of depression in young men may be associated with low vitamin D levels.

Folate commitment will protect babies

Child health expert Professor Fiona Stanley has welcomed today's commitment to proceed with mandatory fortification of food with folate.

An unbiased exploration of the human regulatory landscape

We are made up of hundreds of different cell types carrying out a diverse range of functions essential for organism survival. All the information required to specify the morphology, function and response to stimuli of these cells is encoded in identical copies of the genome. The process of gene regu

Neural tube defects in Australia and food fortification with folic acid

Promotion of periconceptional folic acid supplement use began in Australia following publication of randomised trials showing effectiveness.

Attitudes and behaviour predict women's intention to drink alcohol during pregnancy:

To explore women's alcohol consumption in pregnancy, and potential predictors of alcohol consumption in pregnancy.

Folate decision a win for families

Child health expert Professor Fiona Stanley says today's decision by the Federal and State Food Regulation Ministers to fortify food with folate was a great win

Can the CHA2 DS2 -VA schema be used to decide on anticoagulant therapy in Aboriginal and other Australians with non-valvular atrial fibrillation?

The Australasian guidelines recommend use of the CHA2 DS2 -VA schema to stratify ischaemic stroke risk in patients with non-valvular atrial fibrillation (N-VAF) and determine risk thresholds for recommending oral anticoagulant (OAC) therapy. However, the CHA2 DS2 -VA score has not been validated in a representative Australian population cohort with N-VAF, including in Aboriginal people who are known to have a higher age-adjusted stroke risk than other Australians.

Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection

Benzathine penicillin G has been used as monthly deep intramuscular (IM) injections since the 1950s for secondary prevention of acute rheumatic fever and rheumatic heart disease (RHD). Injection frequency and pain are major programmatic barriers for adherence, prompting calls for development of better long-acting penicillin preparations to prevent RHD.